Phathom Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing new treatments for gastrointestinal (GI) diseases.

Sectors
Healthcare
Biopharma
Life Sciences
First Invested
2023
Public/PIPES
Company Status
IPO/Public
NASDAQ: PHAT